| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.17 | 4e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.21 | 8e-05 |